Cartesian Therapeutics, Inc. Capital Expenditures
Cartesian Therapeutics, Inc. (RNAC) reported Capital Expenditures of $299.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $272.00K, a 89.52% decline year-over-year.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $27.00K, a 97.49% decline year-over-year.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $492.00K, a 30.21% decline year-over-year.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.29M, a 79.16% decline year-over-year.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $5.45M, a 40.02% decline from fiscal 2024.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $9.09M, a 4314.08% increase from fiscal 2023.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $206.00K, a 82.85% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.20M, a 10.69% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $299.00K 10-Q · filed 2026-08-06 | $791.00K derived: sum of 3 quarters · filed 2026-08-06 | $2.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $27.00K 10-Q · filed 2026-04-30 | $519.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.81M derived: sum of 3 quarters · filed 2026-04-30 | $4.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.78M derived: sum of 2 quarters · filed 2026-03-09 | $4.38M derived: sum of 3 quarters · filed 2026-08-06 | $5.45M 10-K · filed 2026-03-09 |
| 2025-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.89M derived: sum of 2 quarters · filed 2026-08-06 | $4.96M 10-Q · filed 2025-11-06 | $5.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.67M 10-Q · filed 2026-08-06 | $4.38M derived: sum of 3 quarters · filed 2026-08-06 | $10.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.07M 10-Q · filed 2026-04-30 | $1.78M derived: sum of 2 quarters · filed 2026-04-30 | $7.98M derived: sum of 3 quarters · filed 2026-04-30 | $9.57M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $6.90M derived: sum of 2 quarters · filed 2026-03-09 | $8.49M derived: sum of 3 quarters · filed 2026-03-09 | $9.09M 10-K · filed 2026-03-09 |
| 2024-09-30 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.79M derived: sum of 2 quarters · filed 2025-11-06 | $8.39M 10-Q · filed 2025-11-06 | $8.45M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.19M 10-Q · filed 2025-08-07 | $2.25M derived: sum of 3 quarters · filed 2025-08-07 | $2.25M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $602.00K 10-Q · filed 2025-05-08 | $666.00K derived: sum of 2 quarters · filed 2025-05-08 | $666.00K derived: sum of 3 quarters · filed 2025-05-08 | $678.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $64.00K derived: sum of 2 quarters · filed 2025-03-13 | $76.00K derived: sum of 3 quarters · filed 2025-03-13 | $206.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $12.00K derived: sum of 2 quarters · filed 2024-11-07 | $142.00K 10-Q · filed 2024-11-07 | $353.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $142.00K 10-Q · filed 2024-08-08 | $353.00K derived: sum of 3 quarters · filed 2024-08-08 | $789.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $130.00K 10-Q · filed 2024-05-08 | $341.00K derived: sum of 2 quarters · filed 2024-05-08 | $777.00K derived: sum of 3 quarters · filed 2024-05-08 | $876.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $647.00K derived: sum of 2 quarters · filed 2024-03-07 | $746.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.20M 10-K · filed 2024-03-07 |
| 2022-09-30 | $436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $535.00K derived: sum of 2 quarters · filed 2023-11-13 | $990.00K 10-Q · filed 2023-11-13 | $1.27M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $554.00K 10-Q · filed 2023-08-17 | $832.00K derived: sum of 3 quarters · filed 2024-03-07 | $996.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $455.00K 10-Q · filed 2023-05-04 | $733.00K derived: sum of 2 quarters · filed 2024-03-07 | $897.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.51M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $442.00K derived: sum of 2 quarters · filed 2024-03-07 | $1.06M derived: sum of 3 quarters · filed 2024-03-07 | $1.08M 10-K · filed 2024-03-07 |
| 2021-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $782.00K derived: sum of 2 quarters · filed 2022-11-03 | $807.00K 10-Q · filed 2022-11-03 | $997.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $618.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $643.00K 10-Q · filed 2022-08-08 | $833.00K derived: sum of 3 quarters · filed 2023-03-02 | $1.12M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-05 | $215.00K derived: sum of 2 quarters · filed 2023-03-02 | $506.00K derived: sum of 3 quarters · filed 2023-03-02 | $705.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $481.00K derived: sum of 2 quarters · filed 2023-03-02 | $680.00K derived: sum of 3 quarters · filed 2023-03-02 | $815.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $490.00K derived: sum of 2 quarters · filed 2021-11-09 | $625.00K 10-Q · filed 2021-11-09 | $662.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $334.00K 10-Q · filed 2021-08-12 | $371.00K derived: sum of 3 quarters · filed 2022-03-10 | $376.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $135.00K 10-Q · filed 2021-05-13 | $172.00K derived: sum of 2 quarters · filed 2022-03-10 | $177.00K derived: sum of 3 quarters · filed 2022-03-10 | $182.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $42.00K derived: sum of 2 quarters · filed 2022-03-10 | $47.00K derived: sum of 3 quarters · filed 2022-03-10 | $47.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.00K derived: sum of 2 quarters · filed 2020-11-05 | $10.00K 10-Q · filed 2020-11-05 | $378.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.00K 10-Q · filed 2020-08-06 | $373.00K derived: sum of 3 quarters · filed 2021-03-12 | $433.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $368.00K derived: sum of 2 quarters · filed 2021-03-12 | $428.00K derived: sum of 3 quarters · filed 2021-03-12 | $692.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $428.00K derived: sum of 2 quarters · filed 2021-03-12 | $692.00K derived: sum of 3 quarters · filed 2021-03-12 | $884.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $324.00K derived: sum of 2 quarters · filed 2019-11-08 | $516.00K 10-Q · filed 2019-11-08 | $665.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $456.00K 10-Q · filed 2019-08-08 | $605.00K derived: sum of 3 quarters · filed 2020-03-12 | $730.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $192.00K 10-Q · filed 2019-05-09 | $341.00K derived: sum of 2 quarters · filed 2020-03-12 | $466.00K derived: sum of 3 quarters · filed 2020-03-12 | $867.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $274.00K derived: sum of 2 quarters · filed 2020-03-12 | $675.00K derived: sum of 3 quarters · filed 2020-03-12 | $733.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $526.00K derived: sum of 2 quarters · filed 2018-11-08 | $584.00K 10-Q · filed 2018-11-08 | $692.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $401.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $459.00K 10-Q · filed 2018-08-08 | $567.00K derived: sum of 3 quarters · filed 2019-03-15 | $843.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $58.00K 10-Q · filed 2018-05-09 | $166.00K derived: sum of 2 quarters · filed 2019-03-15 | $442.00K derived: sum of 3 quarters · filed 2019-03-15 | $501.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $384.00K derived: sum of 2 quarters · filed 2019-03-15 | $443.00K derived: sum of 3 quarters · filed 2019-03-15 | $586.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $335.00K derived: sum of 2 quarters · filed 2017-11-07 | $478.00K 10-Q · filed 2017-11-07 | $610.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $202.00K 10-Q · filed 2017-08-11 | $334.00K derived: sum of 3 quarters · filed 2018-03-15 | $812.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $143.00K 10-Q · filed 2017-05-11 | $275.00K derived: sum of 2 quarters · filed 2018-03-15 | $753.00K derived: sum of 3 quarters · filed 2018-03-15 | |
| 2015-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $610.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.16M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $478.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.03M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $553.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $227.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |